| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |